Copyright Reports & Markets. All rights reserved.

Global Recombinant Human Parathyroid Hormone Market 2026 by Manufacturers, Regions, Type and Application, Forecast to 2032

Request for Sample of this report
Buy now

1 Market Overview

  • 1.1 Product Overview and Scope
  • 1.2 Market Estimation Caveats and Base Year
  • 1.3 Market Analysis by Type
    • 1.3.1 Overview: Global Recombinant Human Parathyroid Hormone Consumption Value by Type: 2021 Versus 2025 Versus 2032
    • 1.3.2 25 mcg/dose
    • 1.3.3 50 mcg/dose
    • 1.3.4 75 mcg/dose
    • 1.3.5 100 mcg/dose
  • 1.4 Market Analysis by Application
    • 1.4.1 Overview: Global Recombinant Human Parathyroid Hormone Consumption Value by Application: 2021 Versus 2025 Versus 2032
    • 1.4.2 Postmenopausal Women with Osteoporosis
    • 1.4.3 Hypocalcemia in Patients with Hypoparathyroidism
  • 1.5 Global Recombinant Human Parathyroid Hormone Market Size & Forecast
    • 1.5.1 Global Recombinant Human Parathyroid Hormone Consumption Value (2021 & 2025 & 2032)
    • 1.5.2 Global Recombinant Human Parathyroid Hormone Sales Quantity (2021-2032)
    • 1.5.3 Global Recombinant Human Parathyroid Hormone Average Price (2021-2032)

2 Manufacturers Profiles

  • 2.1 NPS Pharma(Shire)
    • 2.1.1 NPS Pharma(Shire) Details
    • 2.1.2 NPS Pharma(Shire) Major Business
    • 2.1.3 NPS Pharma(Shire) Recombinant Human Parathyroid Hormone Product and Services
    • 2.1.4 NPS Pharma(Shire) Recombinant Human Parathyroid Hormone Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
    • 2.1.5 NPS Pharma(Shire) Recent Developments/Updates
  • 2.2 Takeda
    • 2.2.1 Takeda Details
    • 2.2.2 Takeda Major Business
    • 2.2.3 Takeda Recombinant Human Parathyroid Hormone Product and Services
    • 2.2.4 Takeda Recombinant Human Parathyroid Hormone Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
    • 2.2.5 Takeda Recent Developments/Updates
  • 2.3 Shandong Buchang Pharmaceuticals
    • 2.3.1 Shandong Buchang Pharmaceuticals Details
    • 2.3.2 Shandong Buchang Pharmaceuticals Major Business
    • 2.3.3 Shandong Buchang Pharmaceuticals Recombinant Human Parathyroid Hormone Product and Services
    • 2.3.4 Shandong Buchang Pharmaceuticals Recombinant Human Parathyroid Hormone Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
    • 2.3.5 Shandong Buchang Pharmaceuticals Recent Developments/Updates
  • 2.4 Ascendis Pharma
    • 2.4.1 Ascendis Pharma Details
    • 2.4.2 Ascendis Pharma Major Business
    • 2.4.3 Ascendis Pharma Recombinant Human Parathyroid Hormone Product and Services
    • 2.4.4 Ascendis Pharma Recombinant Human Parathyroid Hormone Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
    • 2.4.5 Ascendis Pharma Recent Developments/Updates
  • 2.5 Beijing SL Pharmaceutical
    • 2.5.1 Beijing SL Pharmaceutical Details
    • 2.5.2 Beijing SL Pharmaceutical Major Business
    • 2.5.3 Beijing SL Pharmaceutical Recombinant Human Parathyroid Hormone Product and Services
    • 2.5.4 Beijing SL Pharmaceutical Recombinant Human Parathyroid Hormone Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
    • 2.5.5 Beijing SL Pharmaceutical Recent Developments/Updates

3 Competitive Environment: Recombinant Human Parathyroid Hormone by Manufacturer

  • 3.1 Global Recombinant Human Parathyroid Hormone Sales Quantity by Manufacturer (2021-2026)
  • 3.2 Global Recombinant Human Parathyroid Hormone Revenue by Manufacturer (2021-2026)
  • 3.3 Global Recombinant Human Parathyroid Hormone Average Price by Manufacturer (2021-2026)
  • 3.4 Market Share Analysis (2025)
    • 3.4.1 Producer Shipments of Recombinant Human Parathyroid Hormone by Manufacturer Revenue ($MM) and Market Share (%): 2025
    • 3.4.2 Top 3 Recombinant Human Parathyroid Hormone Manufacturer Market Share in 2025
    • 3.4.3 Top 6 Recombinant Human Parathyroid Hormone Manufacturer Market Share in 2025
  • 3.5 Recombinant Human Parathyroid Hormone Market: Overall Company Footprint Analysis
    • 3.5.1 Recombinant Human Parathyroid Hormone Market: Region Footprint
    • 3.5.2 Recombinant Human Parathyroid Hormone Market: Company Product Type Footprint
    • 3.5.3 Recombinant Human Parathyroid Hormone Market: Company Product Application Footprint
  • 3.6 New Market Entrants and Barriers to Market Entry
  • 3.7 Mergers, Acquisition, Agreements, and Collaborations

4 Consumption Analysis by Region

  • 4.1 Global Recombinant Human Parathyroid Hormone Market Size by Region
    • 4.1.1 Global Recombinant Human Parathyroid Hormone Sales Quantity by Region (2021-2032)
    • 4.1.2 Global Recombinant Human Parathyroid Hormone Consumption Value by Region (2021-2032)
    • 4.1.3 Global Recombinant Human Parathyroid Hormone Average Price by Region (2021-2032)
  • 4.2 North America Recombinant Human Parathyroid Hormone Consumption Value (2021-2032)
  • 4.3 Europe Recombinant Human Parathyroid Hormone Consumption Value (2021-2032)
  • 4.4 Asia-Pacific Recombinant Human Parathyroid Hormone Consumption Value (2021-2032)
  • 4.5 South America Recombinant Human Parathyroid Hormone Consumption Value (2021-2032)
  • 4.6 Middle East & Africa Recombinant Human Parathyroid Hormone Consumption Value (2021-2032)

5 Market Segment by Type

  • 5.1 Global Recombinant Human Parathyroid Hormone Sales Quantity by Type (2021-2032)
  • 5.2 Global Recombinant Human Parathyroid Hormone Consumption Value by Type (2021-2032)
  • 5.3 Global Recombinant Human Parathyroid Hormone Average Price by Type (2021-2032)

6 Market Segment by Application

  • 6.1 Global Recombinant Human Parathyroid Hormone Sales Quantity by Application (2021-2032)
  • 6.2 Global Recombinant Human Parathyroid Hormone Consumption Value by Application (2021-2032)
  • 6.3 Global Recombinant Human Parathyroid Hormone Average Price by Application (2021-2032)

7 North America

  • 7.1 North America Recombinant Human Parathyroid Hormone Sales Quantity by Type (2021-2032)
  • 7.2 North America Recombinant Human Parathyroid Hormone Sales Quantity by Application (2021-2032)
  • 7.3 North America Recombinant Human Parathyroid Hormone Market Size by Country
    • 7.3.1 North America Recombinant Human Parathyroid Hormone Sales Quantity by Country (2021-2032)
    • 7.3.2 North America Recombinant Human Parathyroid Hormone Consumption Value by Country (2021-2032)
    • 7.3.3 United States Market Size and Forecast (2021-2032)
    • 7.3.4 Canada Market Size and Forecast (2021-2032)
    • 7.3.5 Mexico Market Size and Forecast (2021-2032)

8 Europe

  • 8.1 Europe Recombinant Human Parathyroid Hormone Sales Quantity by Type (2021-2032)
  • 8.2 Europe Recombinant Human Parathyroid Hormone Sales Quantity by Application (2021-2032)
  • 8.3 Europe Recombinant Human Parathyroid Hormone Market Size by Country
    • 8.3.1 Europe Recombinant Human Parathyroid Hormone Sales Quantity by Country (2021-2032)
    • 8.3.2 Europe Recombinant Human Parathyroid Hormone Consumption Value by Country (2021-2032)
    • 8.3.3 Germany Market Size and Forecast (2021-2032)
    • 8.3.4 France Market Size and Forecast (2021-2032)
    • 8.3.5 United Kingdom Market Size and Forecast (2021-2032)
    • 8.3.6 Russia Market Size and Forecast (2021-2032)
    • 8.3.7 Italy Market Size and Forecast (2021-2032)

9 Asia-Pacific

  • 9.1 Asia-Pacific Recombinant Human Parathyroid Hormone Sales Quantity by Type (2021-2032)
  • 9.2 Asia-Pacific Recombinant Human Parathyroid Hormone Sales Quantity by Application (2021-2032)
  • 9.3 Asia-Pacific Recombinant Human Parathyroid Hormone Market Size by Region
    • 9.3.1 Asia-Pacific Recombinant Human Parathyroid Hormone Sales Quantity by Region (2021-2032)
    • 9.3.2 Asia-Pacific Recombinant Human Parathyroid Hormone Consumption Value by Region (2021-2032)
    • 9.3.3 China Market Size and Forecast (2021-2032)
    • 9.3.4 Japan Market Size and Forecast (2021-2032)
    • 9.3.5 South Korea Market Size and Forecast (2021-2032)
    • 9.3.6 India Market Size and Forecast (2021-2032)
    • 9.3.7 Southeast Asia Market Size and Forecast (2021-2032)
    • 9.3.8 Australia Market Size and Forecast (2021-2032)

10 South America

  • 10.1 South America Recombinant Human Parathyroid Hormone Sales Quantity by Type (2021-2032)
  • 10.2 South America Recombinant Human Parathyroid Hormone Sales Quantity by Application (2021-2032)
  • 10.3 South America Recombinant Human Parathyroid Hormone Market Size by Country
    • 10.3.1 South America Recombinant Human Parathyroid Hormone Sales Quantity by Country (2021-2032)
    • 10.3.2 South America Recombinant Human Parathyroid Hormone Consumption Value by Country (2021-2032)
    • 10.3.3 Brazil Market Size and Forecast (2021-2032)
    • 10.3.4 Argentina Market Size and Forecast (2021-2032)

11 Middle East & Africa

  • 11.1 Middle East & Africa Recombinant Human Parathyroid Hormone Sales Quantity by Type (2021-2032)
  • 11.2 Middle East & Africa Recombinant Human Parathyroid Hormone Sales Quantity by Application (2021-2032)
  • 11.3 Middle East & Africa Recombinant Human Parathyroid Hormone Market Size by Country
    • 11.3.1 Middle East & Africa Recombinant Human Parathyroid Hormone Sales Quantity by Country (2021-2032)
    • 11.3.2 Middle East & Africa Recombinant Human Parathyroid Hormone Consumption Value by Country (2021-2032)
    • 11.3.3 Turkey Market Size and Forecast (2021-2032)
    • 11.3.4 Egypt Market Size and Forecast (2021-2032)
    • 11.3.5 Saudi Arabia Market Size and Forecast (2021-2032)
    • 11.3.6 South Africa Market Size and Forecast (2021-2032)

12 Market Dynamics

  • 12.1 Recombinant Human Parathyroid Hormone Market Drivers
  • 12.2 Recombinant Human Parathyroid Hormone Market Restraints
  • 12.3 Recombinant Human Parathyroid Hormone Trends Analysis
  • 12.4 Porters Five Forces Analysis
    • 12.4.1 Threat of New Entrants
    • 12.4.2 Bargaining Power of Suppliers
    • 12.4.3 Bargaining Power of Buyers
    • 12.4.4 Threat of Substitutes
    • 12.4.5 Competitive Rivalry

13 Raw Material and Industry Chain

  • 13.1 Raw Material of Recombinant Human Parathyroid Hormone and Key Manufacturers
  • 13.2 Manufacturing Costs Percentage of Recombinant Human Parathyroid Hormone
  • 13.3 Recombinant Human Parathyroid Hormone Production Process
  • 13.4 Industry Value Chain Analysis

14 Shipments by Distribution Channel

  • 14.1 Sales Channel
    • 14.1.1 Direct to End-User
    • 14.1.2 Distributors
  • 14.2 Recombinant Human Parathyroid Hormone Typical Distributors
  • 14.3 Recombinant Human Parathyroid Hormone Typical Customers

15 Research Findings and Conclusion

    16 Appendix

    • 16.1 Methodology
    • 16.2 Research Process and Data Source

    According to our (Global Info Research) latest study, the global Recombinant Human Parathyroid Hormone market size was valued at US$ 178 million in 2025 and is forecast to a readjusted size of US$ 279 million by 2032 with a CAGR of 6.6% during review period.
    Recombinant Human Parathyroid Hormone is an artificially manufactured form of the parathyroid hormone used to treat hypoparathyroidism. Recombinant human parathyroid hormone is used in the treatment of osteoporosis in postmenopausal women at high risk of osteoporotic fractures. A significant reduction in the incidence of vertebral fractures has been demonstrated.
    The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
    This report is a detailed and comprehensive analysis for global Recombinant Human Parathyroid Hormone market. Both quantitative and qualitative analyses are presented by manufacturers, by region & country, by Type and by Application. As the market is constantly changing, this report explores the competition, supply and demand trends, as well as key factors that contribute to its changing demands across many markets. Company profiles and product examples of selected competitors, along with market share estimates of some of the selected leaders for the year 2025, are provided.
    Key Features:
    Global Recombinant Human Parathyroid Hormone market size and forecasts, in consumption value ($ Million), sales quantity (K Units), and average selling prices (US$/Unit), 2021-2032
    Global Recombinant Human Parathyroid Hormone market size and forecasts by region and country, in consumption value ($ Million), sales quantity (K Units), and average selling prices (US$/Unit), 2021-2032
    Global Recombinant Human Parathyroid Hormone market size and forecasts, by Type and by Application, in consumption value ($ Million), sales quantity (K Units), and average selling prices (US$/Unit), 2021-2032
    Global Recombinant Human Parathyroid Hormone market shares of main players, shipments in revenue ($ Million), sales quantity (K Units), and ASP (US$/Unit), 2021-2026
    The Primary Objectives in This Report Are:
    To determine the size of the total market opportunity of global and key countries
    To assess the growth potential for Recombinant Human Parathyroid Hormone
    To forecast future growth in each product and end-use market
    To assess competitive factors affecting the marketplace
    This report profiles key players in the global Recombinant Human Parathyroid Hormone market based on the following parameters - company overview, sales quantity, revenue, price, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include NPS Pharma(Shire), Takeda, Shandong Buchang Pharmaceuticals, Ascendis Pharma, Beijing SL Pharmaceutical, etc.
    This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals.
    Market Segmentation
    Recombinant Human Parathyroid Hormone market is split by Type and by Application. For the period 2021-2032, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.
    Market segment by Type
    25 mcg/dose
    50 mcg/dose
    75 mcg/dose
    100 mcg/dose
    Market segment by Application
    Postmenopausal Women with Osteoporosis
    Hypocalcemia in Patients with Hypoparathyroidism
    Major players covered
    NPS Pharma(Shire)
    Takeda
    Shandong Buchang Pharmaceuticals
    Ascendis Pharma
    Beijing SL Pharmaceutical
    Market segment by region, regional analysis covers
    North America (United States, Canada, and Mexico)
    Europe (Germany, France, United Kingdom, Russia, Italy, and Rest of Europe)
    Asia-Pacific (China, Japan, Korea, India, Southeast Asia, and Australia)
    South America (Brazil, Argentina, Colombia, and Rest of South America)
    Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa, and Rest of Middle East & Africa)
    The content of the study subjects, includes a total of 15 chapters:
    Chapter 1, to describe Recombinant Human Parathyroid Hormone product scope, market overview, market estimation caveats and base year.
    Chapter 2, to profile the top manufacturers of Recombinant Human Parathyroid Hormone, with price, sales quantity, revenue, and global market share of Recombinant Human Parathyroid Hormone from 2021 to 2026.
    Chapter 3, the Recombinant Human Parathyroid Hormone competitive situation, sales quantity, revenue, and global market share of top manufacturers are analyzed emphatically by landscape contrast.
    Chapter 4, the Recombinant Human Parathyroid Hormone breakdown data are shown at the regional level, to show the sales quantity, consumption value, and growth by regions, from 2021 to 2032.
    Chapter 5 and 6, to segment the sales by Type and by Application, with sales market share and growth rate by Type, by Application, from 2021 to 2032.
    Chapter 7, 8, 9, 10 and 11, to break the sales data at the country level, with sales quantity, consumption value, and market share for key countries in the world, from 2021 to 2026.and Recombinant Human Parathyroid Hormone market forecast, by regions, by Type, and by Application, with sales and revenue, from 2027 to 2032.
    Chapter 12, market dynamics, drivers, restraints, trends, and Porters Five Forces analysis.
    Chapter 13, the key raw materials and key suppliers, and industry chain of Recombinant Human Parathyroid Hormone.
    Chapter 14 and 15, to describe Recombinant Human Parathyroid Hormone sales channel, distributors, customers, research findings and conclusion.

    Buy now